Mednax Inc Stock Buy Hold or Sell Recommendation
| MD Stock | USD 9.04 0.14 1.57% |
Allowing for the 90-day total investment horizon and your above-average risk tolerance, our recommendation regarding Mednax Inc is 'Hold'. Macroaxis provides Mednax buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Mednax positions. The advice algorithm takes into account all of Mednax's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Mednax's buy or sell advice are summarized below:
Real Value 9.07 | Target Price 14.5 | Hype Value 8.9 | Market Value 9.04 | Naive Value 9.16 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Mednax Inc given historical horizon and risk tolerance towards Mednax. When Macroaxis issues a 'buy' or 'sell' recommendation for Mednax Inc, the advice is generated through an automated system that utilizes algorithms and statistical models.
Mednax |
Execute Mednax Buy or Sell Advice
The Mednax recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Mednax Inc. Macroaxis does not own or have any residual interests in Mednax Inc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Mednax's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Hold | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Mednax Trading Alerts and Improvement Suggestions
| Mednax Inc generated a negative expected return over the last 90 days | |
| The company generated the yearly revenue of 1.99 B. Annual Net Loss to common stockholders was (60.41 M) with gross profit of 467.03 M. | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Pediatrix Medical Group 2024 First Quarter Conference CallWebcast Scheduled for Tuesday, May 7, 2024 |
Mednax Returns Distribution Density
The distribution of Mednax's historical returns is an attempt to chart the uncertainty of Mednax's future price movements. The chart of the probability distribution of Mednax daily returns describes the distribution of returns around its average expected value. We use Mednax Inc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Mednax returns is essential to provide solid investment advice for Mednax.
| Mean Return | -0.09 | Value At Risk | -3.68 | Potential Upside | 3.34 | Standard Deviation | 2.42 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Mednax historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Mednax Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Mednax is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mednax Inc backward and forwards among themselves. Mednax's institutional investor refers to the entity that pools money to purchase Mednax's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Invenomic Capital Management, Lp | 2023-12-31 | 1.4 M | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1.4 M | Boston Partners Global Investors, Inc | 2023-12-31 | 1.3 M | Amvescap Plc. | 2023-12-31 | 1 M | Aristotle Capital Boston, Llc | 2023-12-31 | 824.5 K | Northern Trust Corp | 2023-12-31 | 822.1 K | Bank Of New York Mellon Corp | 2023-12-31 | 741.4 K | Citadel Advisors Llc | 2023-09-30 | 740.1 K | Arrowmark Colorado Holdings, Llc (arrowmark Partners) | 2023-12-31 | 694.2 K | Blackrock Inc | 2023-12-31 | 13.6 M | Vanguard Group Inc | 2023-12-31 | 10.4 M |
Mednax Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 56.0M | 1.0B | (736.5M) | (377.6M) | 63.4M | 66.6M | |
| Free Cash Flow | 314.8M | 175.8M | 44.5M | 137.2M | 104.0M | 182.0M | |
| Depreciation | 78.9M | 28.4M | 32.1M | 35.6M | 36.2M | 32.6M | |
| Other Non Cash Items | 1.5B | 57.7M | (27.8M) | 43.6M | 157.6M | 165.5M | |
| Capital Expenditures | 31.9M | 28.8M | 32.2M | 29.7M | 33.3M | 28.1M | |
| Net Income | (1.2B) | (9.6M) | 108.0M | 62.6M | (60.4M) | (57.4M) | |
| End Period Cash Flow | 112.8M | 1.1B | 387.4M | 9.8M | 73.3M | 93.5M | |
| Change To Netincome | 1.8B | 912.8M | (14.2M) | 31.4M | 36.1M | 34.3M | |
| Change To Inventory | 70.3M | (66.7M) | (34.1M) | (54.9M) | (49.4M) | (46.9M) | |
| Dividends Paid | 2.2B | 1.7B | 526.3M | 470M | 540.5M | 513.5M | |
| Investments | 102.5M | (28.4M) | 1.4M | (57.0M) | (47.0M) | (44.6M) | |
| Net Borrowings | (239.5M) | (1.7M) | (759.8M) | (401.5M) | (361.4M) | (343.3M) |
Mednax Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Mednax or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Mednax's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Mednax stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.15 | |
β | Beta against NYSE Composite | 0.60 | |
σ | Overall volatility | 2.44 | |
Ir | Information ratio | -0.07 |
Mednax Volatility Alert
Mednax Inc exhibits very low volatility with skewness of -0.7 and kurtosis of 1.51. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Mednax's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Mednax's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Mednax Fundamentals Vs Peers
Comparing Mednax's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Mednax's direct or indirect competition across all of the common fundamentals between Mednax and the related equities. This way, we can detect undervalued stocks with similar characteristics as Mednax or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Mednax's fundamental indicators could also be used in its relative valuation, which is a method of valuing Mednax by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Mednax to competition |
| Fundamentals | Mednax | Peer Average |
| Return On Equity | -0.0694 | -0.31 |
| Return On Asset | 0.0432 | -0.14 |
| Profit Margin | (0.03) % | (1.27) % |
| Operating Margin | 0.08 % | (5.51) % |
| Current Valuation | 1.29 B | 16.62 B |
| Shares Outstanding | 84.03 M | 571.82 M |
| Shares Owned By Insiders | 1.37 % | 10.09 % |
| Shares Owned By Institutions | 98.63 % | 39.21 % |
| Number Of Shares Shorted | 4.12 M | 4.71 M |
| Price To Earning | 89.39 X | 28.72 X |
| Price To Book | 0.91 X | 9.51 X |
| Price To Sales | 0.39 X | 11.42 X |
| Revenue | 1.99 B | 9.43 B |
| Gross Profit | 467.03 M | 27.38 B |
| EBITDA | 196.08 M | 3.9 B |
| Net Income | (60.41 M) | 570.98 M |
| Cash And Equivalents | 9.82 M | 2.7 B |
| Cash Per Share | 1.29 X | 5.01 X |
| Total Debt | 701.65 M | 5.32 B |
| Debt To Equity | 1.03 % | 48.70 % |
| Current Ratio | 1.39 X | 2.16 X |
| Book Value Per Share | 10.27 X | 1.93 K |
| Cash Flow From Operations | 137.32 M | 971.22 M |
| Short Ratio | 5.43 X | 4.00 X |
| Price To Earnings To Growth | 0.88 X | 4.89 X |
| Target Price | 9.07 | |
| Number Of Employees | 5.45 K | 18.84 K |
| Beta | 1.58 | -0.15 |
| Market Capitalization | 776.4 M | 19.03 B |
| Total Asset | 2.22 B | 29.47 B |
| Retained Earnings | (149.47 M) | 9.33 B |
| Working Capital | 94.51 M | 1.48 B |
| Current Asset | 527.77 M | 9.34 B |
Note: Disposition of 12923 shares by Pickert Curtis of Mednax subject to Rule 16b-3 [view details]
Mednax Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Mednax . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 19961.67 | |||
| Daily Balance Of Power | 0.5 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 8.98 | |||
| Day Typical Price | 9.0 | |||
| Price Action Indicator | 0.13 | |||
| Period Momentum Indicator | 0.14 |
About Mednax Buy or Sell Advice
When is the right time to buy or sell Mednax Inc? Buying financial instruments such as Mednax Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 1.1B | 753.6M | 701.6M | 521.4M | Total Assets | 2.7B | 2.3B | 2.2B | 2.2B |
Use Investing Ideas to Build Portfolios
In addition to having Mednax in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Technology Thematic Idea Now
Technology
Companies that are involved in development or distribution of technologically based goods and services such as software, IT or electronics. The Technology theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Technology Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Mednax Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Mednax Inc information on this page should be used as a complementary analysis to other Mednax's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Mednax Stock analysis
When running Mednax's price analysis, check to measure Mednax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mednax is operating at the current time. Most of Mednax's value examination focuses on studying past and present price action to predict the probability of Mednax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mednax's price. Additionally, you may evaluate how the addition of Mednax to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is Mednax's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mednax. If investors know Mednax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mednax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.31) | Revenue Per Share 24.265 | Quarterly Revenue Growth (0.03) | Return On Assets 0.0432 | Return On Equity (0.07) |
The market value of Mednax Inc is measured differently than its book value, which is the value of Mednax that is recorded on the company's balance sheet. Investors also form their own opinion of Mednax's value that differs from its market value or its book value, called intrinsic value, which is Mednax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mednax's market value can be influenced by many factors that don't directly affect Mednax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mednax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mednax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mednax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.